BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34423050)

  • 1. Citrullinated Antigens with Multiple Citrulline Similar Motif in the Diagnosis of Rheumatoid Arthritis: A Preliminary Single-Center Study.
    Chen Z; Fang W; Qin Y; Jin YZ; Yang X; Lou J
    J Immunol Res; 2021; 2021():1891519. PubMed ID: 34423050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new pattern of citrullinated peptides improves the sensitivity for diagnosing rheumatoid arthritis.
    Ru Z; Zhang H; Huang X; Lou J; Liao J; Chen Z; Yang X
    Clin Biochem; 2022; 105-106():87-93. PubMed ID: 35398152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
    Schellekens GA; Visser H; de Jong BA; van den Hoogen FH; Hazes JM; Breedveld FC; van Venrooij WJ
    Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
    Snir O; Widhe M; Hermansson M; von Spee C; Lindberg J; Hensen S; Lundberg K; Engström A; Venables PJ; Toes RE; Holmdahl R; Klareskog L; Malmström V
    Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
    Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
    Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
    van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D
    Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis.
    Maraina CH; Nurdayana AK; Rusni D; Azwany Y
    Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
    Us D; Gülmez D; Hasçelik G
    Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.
    Bartoloni E; Alunno A; Bistoni O; Bizzaro N; Migliorini P; Morozzi G; Doria A; Mathieu A; Lotzniker M; Allegri F; Riccieri V; Alpini C; Gabrielli A; Tampoia M; Gerli R;
    Autoimmun Rev; 2012 Sep; 11(11):815-20. PubMed ID: 22394488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 'shared epitope' alleles.
    Wagner CA; Sokolove J; Lahey LJ; Bengtsson C; Saevarsdottir S; Alfredsson L; Delanoy M; Lindstrom TM; Walker RP; Bromberg R; Chandra PE; Binder SR; Klareskog L; Robinson WH
    Ann Rheum Dis; 2015 Mar; 74(3):579-86. PubMed ID: 24297382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.
    Mathsson L; Mullazehi M; Wick MC; Sjöberg O; van Vollenhoven R; Klareskog L; Rönnelid J
    Arthritis Rheum; 2008 Jan; 58(1):36-45. PubMed ID: 18163519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence and diagnostic performance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: the predictive and discriminative ability of serum antibody level in recognizing rheumatoid arthritis.
    Heidari B; Firouzjahi A; Heidari P; Hajian K
    Ann Saudi Med; 2009; 29(6):467-70. PubMed ID: 19847085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis.
    Suzuki K; Sawada T; Murakami A; Matsui T; Tohma S; Nakazono K; Takemura M; Takasaki Y; Mimori T; Yamamoto K
    Scand J Rheumatol; 2003; 32(4):197-204. PubMed ID: 14626625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disordered Antigens and Epitope Overlap Between Anti-Citrullinated Protein Antibodies and Rheumatoid Factor in Rheumatoid Arthritis.
    Zheng Z; Mergaert AM; Fahmy LM; Bawadekar M; Holmes CL; Ong IM; Bridges AJ; Newton MA; Shelef MA
    Arthritis Rheumatol; 2020 Feb; 72(2):262-272. PubMed ID: 31397047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
    Zeng X; Ai M; Tian X; Gan X; Shi Y; Song Q; Tang F
    J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the roles of some immunological biomarkers in the diagnosis of rheumatoid arthritis.
    Khudhair HAA
    J Med Life; 2023 Aug; 16(8):1194-1200. PubMed ID: 38024817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.
    Chang PY; Yang CT; Cheng CH; Yu KH
    Int J Rheum Dis; 2016 Sep; 19(9):880-6. PubMed ID: 25940989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of anti-mutated citrullinated vimentin, anti-cyclic citrullinated peptides, anti-glucose-6-phosphate isomerase and anti-keratin antibodies and rheumatoid factor in the diagnosis of rheumatoid arthritis in Chinese patients.
    Zhu T; Feng L
    Int J Rheum Dis; 2013 Apr; 16(2):157-61. PubMed ID: 23773638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis.
    Bizzaro N; Mazzanti G; Tonutti E; Villalta D; Tozzoli R
    Clin Chem; 2001 Jun; 47(6):1089-93. PubMed ID: 11375296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the analytical and clinical performances of four anti-cyclic citrullinated peptide antibody assays for diagnosing rheumatoid arthritis.
    Cho J; Pyo JY; Fadriquela A; Uh Y; Lee JH
    Clin Rheumatol; 2021 Feb; 40(2):565-573. PubMed ID: 32964298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.